[Special Stock] Mediana Hits Upper Limit Early on News of Home Treatment

[Asia Economy Reporter Myung-Hwan Lee] Mediana's stock price surged up to the 30% limit at the beginning of trading on the 9th due to the impact of the reduction in the delivery targets for home care kits, including oxygen saturation monitors.

As of 10:40 AM on the same day, Mediana was trading at 7,780 KRW, up 29.88% (1,790 KRW) from the previous trading day. Established in 1995, Mediana manufactures and sells medical devices such as oxygen saturation monitors and defibrillators.

The increase in demand for oxygen saturation monitors is attributed to the health authorities' decision to narrow the delivery targets for home care kits. Earlier, as confirmed cases surged due to the spread of Omicron, the health authorities decided to provide home care kits?including oxygen saturation monitors, antipyretics, and thermometers?mainly to confirmed patients in the intensive management group. Accordingly, home care kits are now only provided to confirmed patients aged 60 and above or those in the intensive management group.